Agios Scores Biogen CFO as Board Member
A cancer drug development company that just went public this summer has named the CFO of the biggest biotech around - Biogen Idec Inc. (Nasdaq: BIIB) - as a director...
Related Articles
- Why State Street is Giving Shareholders a Bigger Say over Its Board also published in Business News
- Ariad CEO to Retire Due to Pressure From Shareholders also written by Don Seiffert
- Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board also categorized in BoardMoves
- Analyst: Icahn May Urge Separation of CEO. Chairman Roles at Nuance also written by Don Seiffert
- New Baxter CEO Steps Down From EMC Board also published in Business News
- Target CEO Gregg Steinhafel Resigns In Data Breach Fallout also categorized in BoardMoves
- PepsiCo Puts Trian Business Advisor On Board also categorized in BoardMoves
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- Ariad's "Poison Pill" Plan Comes After Former Icahn Exec Buys Stake also written by Don Seiffert
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
Login to comment.